ProciseDx Patents – Insights & Stats (Updated 2024)

ProciseDx has a total of 37 patents globally, out of which 6 have been granted. Of these 37 patents, more than 59% patents are active. United States of America is where ProciseDx has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of ProciseDx.

ProciseDx was founded in the year 2018. The Company operates as a biopharmaceutical company. The Company focuses on the development of therapeutics and companion diagnostics for inflammatory bowel diseases.

Do read about some of the most popular patents of ProciseDx which have been covered by us in this article and also you can find ProciseDx patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ProciseDx patent portfolio.

How many patents does ProciseDx have?

ProciseDx has a total of 37 patents globally. These patents belong to 16 unique patent families. Out of 37 patents, 22 patents are active.

How Many Patents did ProciseDx File Every Year?

ProciseDx Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantProciseDx Applications FiledProciseDx Patents Granted
20232
202231
202193
202017
20195
20181
20171
20161

How many ProciseDx patents are Alive/Dead?

ProciseDx Patent Portfolio

 How Many Patents did ProciseDx File in Different Countries?

ProciseDx Worldwide Patent Filing

Countries in which ProciseDx Filed Patents

CountryPatents
United States Of America15
Europe11
Austria1
Spain1

Where are Research Centres of ProciseDx Patents Located?

R&D Centers of ProciseDx

Best ProciseDx Patents

US20200222896A1 is the most popular patent in the ProciseDx portfolio. It has received 3 citations so far from company like Gen-Probe Incorporated.

What Percentage of ProciseDx US Patent Applications were Granted?

ProciseDx (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 33.33%.

Below are the key stats of ProciseDx patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for ProciseDx?

Law FirmTotal ApplicationsSuccess Rate
Kilpatrick Townsend & Stockton Llp1033.33%

List of ProciseDx Patents

ProciseDx PatentsTitle
US11119043B2Analyzer
US11119096B2Universal Assay For Determining The Quantity Of Therapeutic Monoclonal Antibodies And Their Corresponding Anti-Drug-Antibodies In Samples
US11085931B2Universal Assay For Determining The Quantity Of Tnfα Inhibitory Drugs And Their Corresponding Anti-Drug-Antibodies
US20240012007A9Assay Method For The Detection Of Vcam-1 And Alpha-2-Macroglobulin In Blood
US20230160906A1Detection Of Anti-Tnf Alpha Drug Biologics And Anti-Drug Antibodies
US20230131780A1Methods Of Detecting Antibodies To Sars-Cov-2
US20230108128A1Predetermined Calibration Curve
US20220283173A1Differential Detection Of Viral And Bacterial Infections
US20220155230A1Light Source Accommodation For Different Sample Matrices
US20220146501A1Assay Methods For The Detection Of Human Serum Albumin, Vitamin D, C-Reactive Protein, And Anti-Transglutaminase Autoantibody
US20220137035A1Detection Of Hemoglobin A1C (Hba1C) In Blood
US20210405063A1Assay Detection Methods For Vcam-1 And Calprotectin
US20210307729A1Fecal Sampler
EP3752819B1Analyzer
EP3821250B1An Assay Method For The Detection Of Vcam-1 And Alpha-2-Macroglobulin In Blood
EP3990894A1Methods For Accommodating For Sample Matrix Effects In Light Measurement Assays
EP3990922A1Detection Of Anti-Tnf Alpha Drug Biologics And Anti-Drug Antibodies
EP3973290A1Assay Methods For The Detection Of Human Serum Albumin, Vitamin D, C-Reactive Protein, And Anti-Transglutaminase Autoantibody
EP3969906A1Assay Detection Methods For Vcam-1 And Calprotectin
EP3880083A1Fecal Sampler
EP3568398A1Cryptate Derivatives And Their Use As Luminescent Lanthanide Complexes
ES2956109T3Analyzer
US20200222896A1Assay Cuvette
US20190284211A1Cryptates And Methods Of Use
EP4070104A2Differential Detection Of Viral And Bacterial Infections
EP3980779A1Detection Of Hemoglobin A1C (Hba1C) In Blood
EP3752289A1Assay Cuvette
AT1489581TTest method for detecting Vcam-1 and alpha-2 macroglobulin in blood
WO2021242725A1Predetermined Calibration Curve
WO2021222533A1Methods Of Detecting Antibodies To Sars-Cov-2
WO2021113457A3Differential Detection Of Viral And Bacterial Infections
WO2020263450A1Detection Of Anti-Tnf Alpha Drug Biologics And Anti-Drug Antibodies
WO2020264295A1Methods For Accommodating For Sample Matrix Effects In Light Measurement Assays
WO2020247159A1Detection Of Hemoglobin A1C (Hba1C) In Blood
WO2020236528A1Assay Methods For The Detection Of Human Serum Albumin, Vitamin D, C-Reactive Protein, And Anti-Transglutaminase Autoantibody
WO2020232295A1An Assay Method For The Detection Of Vcam-1 And Alpha-2-Macroglobulin In Blood
WO2020232262A1Assay Detection Methods For Vcam-1 And Calprotectin

What are ProciseDx key innovation segments?

What Technologies are Covered by ProciseDx?

The chart below distributes patents filed by ProciseDx in different countries on the basis of the technology protected in patents. It also represents the markets where ProciseDx thinks it’s important to protect particular technology inventions.

R&D Focus: How has ProciseDx search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by ProciseDx?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.